Romiplostim - Khk


Indications and Reactions:

Role Indications Reactions
Primary
Idiopathic Thrombocytopenic Purpura 25.0%
Prophylaxis 19.1%
Hypertension 10.5%
Immune Thrombocytopenic Purpura 10.0%
Insomnia 3.8%
Constipation 3.7%
Gastritis 3.7%
Gastrointestinal Haemorrhage 3.5%
Diabetes Mellitus 2.9%
Osteoporosis 2.9%
Eating Disorder 2.6%
Hyperuricaemia 2.6%
Upper Gastrointestinal Haemorrhage 1.6%
Chronic Obstructive Pulmonary Disease 1.4%
Uterine Leiomyoma 1.4%
Hyperlipidaemia 1.3%
Gastrooesophageal Reflux Disease 1.1%
Benign Prostatic Hyperplasia 1.0%
Cardiac Failure 1.0%
Iron Deficiency Anaemia 1.0%
White Blood Cell Count Increased 15.1%
Myelodysplastic Syndrome 9.4%
Sepsis 7.5%
Acute Respiratory Failure 5.7%
Pulmonary Embolism 5.7%
Renal Disorder 5.7%
Cerebral Haemorrhage 3.8%
Circulatory Collapse 3.8%
Femoral Artery Occlusion 3.8%
Gastrointestinal Haemorrhage 3.8%
Haemorrhagic Diathesis 3.8%
Hepatic Neoplasm Malignant 3.8%
Myocardial Infarction 3.8%
Neutrophil Count Increased 3.8%
Platelet Count Decreased 3.8%
Purpura 3.8%
Thrombocytopenia 3.8%
Upper Gastrointestinal Haemorrhage 3.8%
White Blood Cell Count Decreased 3.8%
Anaemia 1.9%
Secondary
Idiopathic Thrombocytopenic Purpura 28.2%
Prophylaxis 18.7%
Hypertension 9.3%
Immune Thrombocytopenic Purpura 6.4%
Constipation 5.2%
Insomnia 5.0%
Hyperuricaemia 3.9%
Gastritis 3.4%
Osteoporosis 2.7%
Hyperlipidaemia 2.5%
Diabetes Mellitus 1.8%
Anal Haemorrhage 1.7%
Chronic Obstructive Pulmonary Disease 1.6%
Abdominal Pain 1.5%
Bronchitis 1.5%
Upper Respiratory Tract Inflammation 1.5%
Gastrooesophageal Reflux Disease 1.4%
Epilepsy 1.3%
Nephrogenic Anaemia 1.2%
Parkinson's Disease 1.1%
White Blood Cell Count Increased 16.1%
Hepatic Neoplasm Malignant 14.3%
Dizziness Postural 7.8%
Nasal Vestibulitis 7.8%
Pulmonary Embolism 7.5%
Renal Disorder 7.2%
Myelodysplastic Syndrome 5.7%
Death 3.3%
Hepatic Function Abnormal 3.3%
Liver Disorder 3.3%
Arrhythmia 3.0%
Femoral Artery Occlusion 3.0%
Constipation 2.7%
Purpura 2.4%
Rhinitis Allergic 2.4%
Sepsis 2.4%
White Blood Cell Count Decreased 2.4%
Thrombocytopenia 2.1%
Anaemia 1.8%
Brain Stem Infarction 1.8%

Drug Data